Search Results - "Pego‐Reigosa, Jose María"

Switching between reference adalimumab and biosimilars in chronic immune‐mediated inflammatory diseases: A systematic literature review by García‐Beloso, Nerea, Altabás‐González, Irene, Samartín‐Ucha, Marisol, Gayoso‐Rey, Mónica, De Castro‐Parga, María Luísa, Salgado‐Barreira, Ángel, Cibeira‐Badia, Amelia, Piñeiro‐Corrales, María Guadalupe, González‐Vilas, Daniel, Pego‐Reigosa, Jose María, Martínez‐López de Castro, Noemí

“…Aims Adalimumab is a biological therapy used to treat different chronic inflammatory diseases. At present, there is an increasing number of adalimumab…”
Get full text

Semaphorin3B promotes an anti-inflammatory and pro-resolving phenotype in macrophages from rheumatoid arthritis patients in a MerTK-dependent manner by Martínez-Ramos, Sara, Rafael-Vidal, Carlos, Malvar-Fernández, Beatriz, Pérez, Nair, Mouriño, Coral, Pérez, Sara García, Maceiras Pan, Francisco J, Conde, Carmen, Pego-Reigosa, Jose María, García, Samuel

“…Previous works from our group show that Semaphorin3B (Sema3B) is reduced in RA and plays a protective role in a mouse arthritis model. In turn, MerTK plays a…”
Get full text

Genome-wide association study meta-analysis identifies five new loci for systemic lupus erythematosus by Julià, Antonio, López-Longo, Francisco Javier, Pérez Venegas, José J, Bonàs-Guarch, Silvia, Olivé, Àlex, Andreu, José Luís, Aguirre-Zamorano, Mª Ángeles, Vela, Paloma, Nolla, Joan M, de la Fuente, José Luís Marenco, Zea, Antonio, Pego-Reigosa, José María, Freire, Mercedes, Díez, Elvira, Rodríguez-Almaraz, Esther, Carreira, Patricia, Blanco, Ricardo, Taboada, Víctor Martínez, López-Lasanta, María, Corbeto, Mireia López, Mercader, Josep M, Torrents, David, Absher, Devin, Marsal, Sara, Fernández-Nebro, Antonio

“…Systemic lupus erythematosus (SLE) is a common systemic autoimmune disease with a complex genetic inheritance. Genome-wide association studies (GWAS) have…”
Get full text

Primary respiratory disease in patients with systemic lupus erythematosus: data from the Spanish rheumatology society lupus registry (RELESSER) cohort by Narváez, Javier, Borrell, Helena, Sánchez-Alonso, Fernando, Rúa-Figueroa, Iñigo, López-Longo, Francisco Javier, Galindo-Izquierdo, María, Calvo-Alén, Jaime, Fernández-Nebro, Antonio, Olivé, Alejandro, Andreu, José Luis, Martínez-Taboada, Víctor, Nolla, Joan Miquel, Pego-Reigosa, José María

“…The purpose of this study was to assess the prevalence, associated factors, and impact on mortality of primary respiratory disease in a large systemic lupus…”
Get full text

Efficacy and safety of rituximab in the treatment of non-renal systemic lupus erythematosus: A systematic review by Cobo-Ibáñez, Tatiana, MD, PhD, Loza-Santamaría, Estíbaliz, MD, Pego-Reigosa, José María, MD, PhD, Marqués, Alejandro Olivé, MD, PhD, Rúa-Figueroa, Íñigo, MD, Fernández-Nebro, Antonio, MD, PhD, Cáliz, Rafael Cáliz, MD, López Longo, Francisco Javier, MD, PhD, Muñoz-Fernández, Santiago, MD, PhD

“…Abstract Objective To analyse the efficacy and safety of rituximab in the treatment of non-renal systemic lupus erythematosus (SLE). Methods We systematically…”
Get full text

Hormonal Dependence and Cancer in Systemic Lupus Erythematosus by Cobo‐Ibáñez, Tatiana, Urruticoechea‐Arana, Ana, Rúa‐Figueroa, Iñigo, Martín‐Martínez, María A., Ovalles‐Bonilla, Juan Gabriel, Galindo, María, Calvo‐Alén, Jaime, Olivé, Alejandro, Fernández‐Nebro, Antonio, Menor‐Almagro, Raúl, Tomero, Eva, Horcada, Loreto, Uriarte‐Itzazelaia, Esther, Martínez‐Taboada, Víctor M., Andreu, José Luis, Boteanu, Alina, Narváez, Javier, Bohorquez, Cristina, Montilla, Carlos, Santos, Gregorio, Hernández‐Cruz, Blanca, Vela, Paloma, Salgado, Eva, Freire, Mercedes, Hernández‐Beriain, José Ángel, Díez‐Álvarez, Elvira, Expósito, Lorena, Fernández‐Berrizbeitia, Olaia, Velloso‐Feijoo, María Luisa, Ibáñez‐Barceló, Mónica, Lozano‐Rivas, Nuria, Bonilla, Gema, Moreno, Mireia, Raya, Enrique, Quevedo‐Vila, Víctor Eliseo, Vázquez‐Rodríguez, Tomas Ramón, Ibáñez‐Ruan, Jesús, Muñoz‐Fernández, Santiago, Sánchez‐Alonso, Fernando, Pego‐Reigosa, José María

“…Objective To estimate the incidence and analyze any cancer‐associated factors in patients with systemic lupus erythematosus (SLE), differentiating between…”
Get full text

Respiratory manifestations of systemic lupus erythematosus: old and new concepts by Pego-Reigosa, José María, MD, PhD, Consultant Rhumatologist, Doctor, Medeiros, Dina A., MD, Doctor, Isenberg, David A., MD, FRCP, Professor of Rheumatology

“…The respiratory system is commonly involved in systemic lupus erythematosus. Lung disorders are classified as primary (due to lupus) and secondary to other…”
Get full text

Biological therapy for systemic vasculitis: A systematic review by Silva-Fernández, Lucía, MD, MSc, Loza, Estíbaliz, MD, Martínez-Taboada, Víctor M., MD, PhD, Blanco, Ricardo, MD, PhD, Rúa-Figueroa, Íñigo, MD, Pego-Reigosa, José María, MD, PhD, Muñoz-Fernández, Santiago, MD, PhD

“…Abstract Objective Relapses and failure are frequent in systemic vasculitis (SV) patients. Biological agents have been prescribed as rescue therapies. The aim…”
Get full text

HOXA5 is a key regulator of class 3 semaphorins expression in the synovium of rheumatoid arthritis patients by Martínez-Ramos, Sara, Rafael-Vidal, Carlos, Malvar-Fernández, Beatriz, Rodriguez-Trillo, Angela, Veale, Douglas, Fearon, Ursula, Conde, Carmen, Conde-Aranda, Javier, Radstake, Timothy R D J, Pego-Reigosa, Jose María, Reedquist, Kris A, García, Samuel

“…Abstract Objective Class 3 semaphorins are reduced in the synovial tissue of RA patients and these proteins are involved in the pathogenesis of the disease…”
Get full text

What are the topics you care about making trials in lupus more effective? Results of an Open Space meeting of international lupus experts by Mucke, Johanna, Alarcon-Riquelme, Marta, Andersen, Jeanette, Aringer, Martin, Bombardieri, Stefano, Brinks, Ralph, Cervera, Ricard, Chehab, Gamal, Cornet, Alain, Costedoat-Chalumeau, Nathalie, Czirják, László, Doria, Andrea, Fischer-Betz, Rebecca, Furie, Richard A, Gatto, Mariele, Houssiau, Frédéric A, Ines, Luis, Liang, Matthew H, Morand, Eric, Mosca, Marta, Pego-Reigosa, José María, Rúa-Figueroa, Iñigo, Ruiz-Irastorza, Guillermo, Terrier, Benjamin, Voss, Anne, Schneider, Matthias

“…Despite promising candidates for new therapeutic options in the treatment of systemic lupus erythematosus (SLE), many clinical trials have failed in the past…”
Get full text

Novel endothelial progenitor cells populations as biomarkers of damage and remission in systemic lupus erythematosus by Rafael-Vidal, Carlos, Martínez-Ramos, Sara, Malvar-Fernández, Beatriz, Altabás-González, Irene, Mouriño, Coral, Pazos-López, Pablo, Fraga-Bau, Arturo, Pego Reigosa, José María, García, Samuel

“…Endothelial progenitor cells (EPCs) are essential for maintenance of vascular homeostasis and stability, key processes in the pathogenesis of systemic lupus…”
Get full text

Biological therapy safety in chronic inflammatory arthropathy patients by Martínez-López-de-Castro, Noemi, Álvarez-Payero, Miriam, Samartín-Ucha, Marisol, Martín-Vila, Alicia, Piñeiro-Corrales, Guadalupe, Rodríguez-Rodríguez, María, Maceiras-Pan, Francisco José, Melero-González, Rafael Benito, Pego-Reigosa, Jose María

“…Objective: The marketing of biological therapies transformed the treatment of rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis. But there…”
Get full text

Diffuse alveolar hemorrhage in patients with systemic lupus erythematosus: data from the Spanish society of rheumathology Lupus Register (RELESSER) by Garcia-Villanueva, María Jesús, Garrote-Corral, Sandra, Pego-Reigosa, Jose María, Jiménez Otero, Norman, Uriarte Isazelaia, Esther, Olivé Marqué, Alejandro, Sangüesa Gómez, Clara, Freire González, Mercedes, Aurrecoechea Aguinaga, Elena, Raya Álvarez, Enrique, Tomero Muriel, Eva, Montilla Morales, Carlos, Galindo Izquierdo, María, Calvo-Alén, Jaime, Menor-Almagro, Raúl, Serrano Benavente, Belén, Martinez-Barrio, Julia, Hernández-Beriain, Jose Angel, Ibañez Barceló, Mónica, Bonilla Hernan, Gema, Rosas, Jose, Salgado Pérez, Eva, Fernández-Nebro, Antonio, Rua-Figueroa, Iñigo

“…Introduction:  Diffuse alveolar hemorrhage (DAH) is a rare complication with high mortality in patients with systemic lupus erythematosus (SLE). Early…”
Get full text

Type I Interferons induce endothelial destabilization in Systemic Lupus Erythematosus in a Tie2-dependent manner by Rafael-Vidal, Carlos, Martínez-Ramos, Sara, Malvar-Fernández, Beatriz, Altabás-González, Irene, Mouriño, Coral, Veale, Douglas J, Floudas, Achilleas, Fearon, Ursula, Reigosa, José María Pego, García, Samuel

“…Endothelial cell (EC) dysfunction is a hallmark of Systemic Lupus Erythematosus (SLE) and Tie2 is a receptor essential for vascular stability. Inflammatory…”
Get full text

Analysis of the implementation of an innovative IT solution to improve waiting times, communication with primary care and efficiency in Rheumatology by Pego-Reigosa, José María, Peña-Gil, Carlos, Rodríguez-Lorenzo, David, Altabás-González, Irene, Pérez-Gómez, Naír, Guzmán-Castro, John Henry, Varela-Gestoso, Rodrigo, Díaz-Lambarri, Reyes, González-Carreró-López, Alberto, Míguez-Senra, Olga, Bóveda-Fontán, Julia, Charle-Crespo, Ángeles, Caramés-Casal, Francisco Javier, Barbazán-Álvarez, Ceferino, Hernández-Rodríguez, Íñigo, Maceiras-Pan, Francisco, Rodríguez-López, Marina, Melero-González, Rafael, Rodríguez-Fernández, José Benito

“…To describe in detail an innovative program based on telemedicine for semi-automated prioritization of referrals from Primary Care (PC) to Rheumatology, for…”
Get full text

P8 Novel endothelial progenitor cells populations as biomarkers of damage and remission in systemic lupus erythematosus by Rafael-Vidal, Carlos, Martínez-Ramos, Sara, Malvar-Fernández, Beatriz, Altabás-González, Irene, Mouriño, Coral, Pazos-López, Pablo, Fraga-Bau, Arturo, Pego Reigosa, José María, García, Samuel

“…ObjectiveEndothelial progenitor cells (EPCs) are essential for maintenance of vascular homeostasis and stability, which are key processes in the pathogenesis…”
Get full text

Multidisciplinary models for pregnancy care in patients with rheumatic diseases: Clinical experiences and experts opinion by Pluma, Andrea, Alsina, Laia, Baniandres, Ofelia, Caliz, Rafael, Casellas, Manel, Grados, Dolors, Martınez Lopez, Juan Antonio, Perez, Erika Padron, Polo, Ana, Pego Reigosa, Jose Maria, Trujillo, Elisa, Vela, Paloma

“…To describe different models of multidisciplinary pregnancy care for patients with inflammatory and autoimmune rheumatic diseases, and the steps to follow…”
Get full text

Efficacy of Raynaud’s phenomenon and digital ulcer pharmacological treatment in systemic sclerosis patients: a systematic literature review by García de la Peña Lefebvre, Paloma, Nishishinya, María Betina, Pereda, Claudia Alejandra, Loza, Estíbaliz, Sifuentes Giraldo, Walter Alberto, Román Ivorra, José Andrés, Carreira, Patricia, Rúa-Figueroa, Iñigo, Pego-Reigosa, Jose María, Muñoz-Fernández, Santiago

“…To evaluate the efficacy of current treatments for the Raynaud phenomenon (RP) in patients with systemic sclerosis (SSc), a systematic literature search was…”
Get full text

The risk of infections in adult patients with systemic lupus erythematosus: systematic review and meta-analysis by Pego-Reigosa, José María, Nicholson, Lindsay, Pooley, Nick, Langham, Sue, Embleton, Nina, Marjenberg, Zoe, Barut, Volkan, Desta, Barnabas, Wang, Xia, Langham, Julia, Hammond, Edward R

“…Abstract Objectives We conducted a systematic review and meta-analysis to determine the magnitude of infection risk in patients with SLE and evaluate the…”
Get full text

Does remission in systemic lupus erythematosus according to the 2021 DORIS definition match the treating rheumatologist's judgement? by Altabás-González, Irene, Rúa-Figueroa, Íñigo, Rubiño, Francisco, Mouriño, Coral, Hernández-Rodriguez, Íñigo, Menor-Almagro, Raúl, Uriarte-Isacelaya, Esther, Tomero, Eva, Salman-Monte, Tarek C, Carrión-Barberá, Irene, Galindo-Izquierdo, Maria, Rodriguez-Almaraz, M Esther, Inês, Luís S, Jiménez, Norman, Pego-Reigosa, José María

“…To assess agreement between the 2021 Definition Of Remission In SLE (DORIS) and physician-judged lupus activity. A cross-sectional analysis was conducted of…”
Get full text